Publication | Open Access

Bufalin derivative BF211 inhibits proteasome activity in human lung cancer cells in vitro by inhibiting β1 subunit expression and disrupting proteasome assembly

MedicineProteasomeProtein DegradationProteasome AssemblyAnti-cancer AgentBufalin Derivative Bf211Radiation OncologyCancer BiologyCell BiologyCancer ResearchLung CancerTumor BiologyProteasome ActivityHealth Sciences